Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emmanuel Eroume A. Egom"'
Autor:
Emmanuel Eroume A. Egom
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Heart failure (HF) with preserved ejection fraction (HFpEF) is a major public health problem with cases projected to double over the next two decades. There are currently no US Food and Drug Administration–approved therapies for the health-related
Externí odkaz:
https://doaj.org/article/0ba91c72cc5b47349dda6e6f8134633a
Autor:
Mohammed Ali, Haaris A. Shiwani, Mohammed Y. Elfaki, Moaz Hamid, Rebabonye Pharithi, Rene Kamgang, Christian BinounA Egom, Jean Louis Essame Oyono, Emmanuel Eroume-A Egom
Publikováno v:
The Egyptian Heart Journal, Vol 74, Iss 1, Pp 1-9 (2022)
Abstract Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 myocarditis seems to have distinc
Externí odkaz:
https://doaj.org/article/a062131c24174552b737d8b0b6a567fd
Autor:
Emmanuel Eroume-A Egom, Rene Kamgang, Christian Binoun A Egom, Roger Moyou-Somo, Jean Louis Essame Oyono
Publikováno v:
Therapeutic Advances in Reproductive Health, Vol 14 (2020)
Externí odkaz:
https://doaj.org/article/5d8bf6644dfd47aba12ad4fbd2d45983
Autor:
Emmanuel Eroume-A Egom, Rene Kamgang
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/fa7e26c012e34614af8446befb5ae18f
Publikováno v:
Frontiers in Physiology. 13
As the world progressively recovers from the acute stages of the coronavirus disease 2019 (COVID-19) pandemic, we may be facing new challenges regarding the long-term consequences of COVID-19. Accumulating evidence suggests that pulmonary vascular th
Publikováno v:
The Application of Clinical Genetics
Pulmonary Arterial Hypertension (PAH) is a progressive and devastating disease for which there is an escalating body of genetic and related pathophysiological information on disease pathobiology. Nevertheless, the success to date in identifying susce
Autor:
Emmanuel Eroume A Egom, mamas emamas, Sanoj eChacko, Sally E Stringer, Magdi eEl-Omar, Debora eChirico, Bernard eClarke, Ludwig eNeyses, Kennedy eCruickshank, Ming eLei, Farzin eFath-Ordoubadi
Publikováno v:
Frontiers in Physiology, Vol 4 (2013)
Background: Ventricular tachyarrhythmias are the most common and often the first manifestation of coronary heart disease and lead to sudden cardiac death. Early detection/identification of acute myocardial ischaemic injury at risk for malignant ventr
Externí odkaz:
https://doaj.org/article/80961ed3827347b9aafe21559be84591
Autor:
Emmanuel Eroume-A, Egom, Tiam, Feridooni, Rebabonye B, Pharithi, Barkat, Khan, Haaris A, Shiwani, Vincent, Maher, Yassine, El Hiani, Robert A, Rose, Kishore Bs, Pasumarthi, Hilaire A, Ribama
Publikováno v:
International journal of physiology, pathophysiology and pharmacology. 9(5)
Background: Pulmonary Arterial Hypertension (PAH) is a deadly and disabling disease for which there is no marketed drug that addresses the underlying disease mechanism and targets to cure patients. The lack of understanding of the disease mechanism r
Autor:
Emmanuel Eroume A, Egom, Hafsa, Hafeez
Publikováno v:
Advances in clinical chemistry. 73
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Elevated blood lipids may be a major risk factor for CVD. Due to consistent and robust association of higher low-density lipoprotein (LDL)-cholesterol levels with